KeyBanc raised the firm’s price target on Ametek (AME) to $235 from $220 and keeps an Overweight rating on the shares. The firm cites its views of modestly improving short-cycle activity, slightly higher margin benefits from the FARO acquisition, and balance sheet health plus available liquidity for additional M&A.
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AME:
- Ametek upgraded to Buy from Hold at Melius Research
- Ametek price target raised to $230 from $225 at Mizuho
- Ametek, MindMed, Atai, Prime and KB Home Trending
- Midday Fly By: Wegovy weight loss pill approved, ServiceNow inks security deal
- Early notable gainers among liquid option names on December 23rd